DSM-Firmenich stock: shareholders elect chair pre-market today
Published on 10/20/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSShareholder vote changes board leadership
- DSM-Firmenich shareholders elected Richard Ridinger as chairman on October 19, 2026.
- The company describes its business as combining nutrients, flavors and fragrances for nutrition, health and beauty.
- DSM-Firmenich stock trades pre-market at EUR 109.20 at 7:48 a.m. CEST at Lang & Schwarz on October 20, 2026.
DSM-Firmenich shareholders elected Richard Ridinger as chairman at an Extraordinary General Meeting held on October 19, 2026, according to an issuer press release distributed by GlobeNewswire. Richard Ridinger succeeds Thomas Leysen, who retired from the board. The new chairman had served as an independent board member since 2023 and was also elected to the Compensation Committee. DSM-Firmenich stock trades pre-market at EUR 109.20 at 7:48 a.m. CEST at Lang & Schwarz on October 20, 2026.
New chairman elected
The company said the EGM vote confirmed Richard Ridinger as chairman and that the detailed voting results would be published on its website. The release identified the announcement as an ad hoc disclosure under Article 53 of the listing regulations and said Thomas Leysen had retired from the board. The company also said Ridinger brings experience across pharmaceuticals, home and personal care, and nutrition and health, according to GlobeNewswire.
Ahead of the Xetra open
Lang & Schwarz shows a bid of EUR 108.80 and an ask of EUR 109.60. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of DSM-Firmenich stock.
The group and its market
DSM-Firmenich reinvents, manufactures and combines nutrients, flavors and fragrances for nutrition, health and beauty markets, according to the October 19, 2026 release. The company said it is listed on Euronext Amsterdam and SIX Swiss Exchange. Market context: Market report Euro Stoxx 50.
